(Q73035188)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12600424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Costs of prostate cancer, metastatic to the bone, in the Netherlands (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12600424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

M T Groot

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12600424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

C G G Boeken Kruger

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12600424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

R C M Pelger

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12600424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

C A Uyl-de Groot

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12600424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12600424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12600424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12600424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12600424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

226-232

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12600424%20AND%20SRC:MED&resulttype=core&format=json

A prospective study of factors predicting clinically occult spinal cord compression in patients with metastatic prostate carcinoma

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

Morphometric evidence for bone resorption and replacement in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

Disodium pamidronate identifies differential osteoclastic bone resorption in metastatic prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

Markers of bone turnover for the management of patients with bone metastases from prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

The effect of clodronate on bone in metastatic prostate cancer. Histomorphometric report of a double-blind randomised placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

Treatment with radioactive (89)strontium for patients with bone metastases from prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

Advanced prostate cancer: course, care, and cost implications

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

Cost analysis of CHOP (-like) chemotherapy regimens for patients with newly diagnosed aggressive non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

Follow-up of prostate cancer patients by on-demand contacts with a specialist nurse: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

Costs of home care for advanced breast and cervical cancer in relation to cost-effectiveness of screening

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

Treatment of painful prostatic bone metastases with oral etidronate disodium

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

Osteoclast inhibition by pamidronate in metastatic prostate cancer: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

Pain relief and quality-of-life assessment following intravenous and oral clodronate in hormone-escaped metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

Effects of the bisphosphonate olpadronate in patients with carcinoma of the prostate metastatic to the skeleton

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

A review of quality-of-life evaluations in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

High-dose intravenous pamidronate for metastatic bone pain

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900007-1

7 January 2021

10.1016/S0302-2838(03)00007-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12600424%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference